1
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Hormone replacement therapy by implant: the need to rethink

Pages 316-318 | Published online: 02 Jul 2009

References

  • Barlow D. H., Abdalla H. I., Roberts A. D. G., Al‐Azawi F., Leggate I., Hart D. M. Long term hormone implant therapy–hormonal and clinical effects. Obstetrics and Gynecology 1986; 67: 321–325
  • Barrett‐Connor E. Postmenopausal estrogen replacement and breast cancer. New England Journal of Medicine 1989; 321: 319–320
  • Bergkvist L., Adami H., Persson I., Hoover R., Schairer C. The risk of breast cancer after estrogen‐progestin replacement. New England Journal of Medicine 1989; 321: 293–297
  • Brincat M., Magos A., Studd J. W. W., Cardozo L. D., O'Dowd T., Wardle P. J., Cooper D. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet 1984; i: 16–18
  • Collins W. P. Ovarian steroid hormones. Scientific Foundations of Obstetrics and Gynaecology, E. Phillip, J. Barnes, M. Newton. William Heinemann Medical Books, London 1986; 465–472
  • Gangar K., Cust M., Whitehead M. I. Symptoms of oestrogen deficiency associated with supra‐physiological plasma oestradiol concentrations in women with oestradiol implants. British Medical Journal 1989; 299: 601–602
  • Garnett T., Studd J. W. W., Henderson A., Watson N., Savvas M., Leather A. Hormone implants and tachyphylaxis. British Journal of Obstetrics and Gynaecology 1990; 97: 917–921
  • Hunt K., Vessey M., McPherson K., Coleman M. Long term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. British Journal of Obstetrics and Gynaecology 1987; 94: 620–635
  • Manyonda I. T., Pereira R. S., Makinde V., Brincat M., Varma R. T. Effect of 17B‐oestradiol on lymphocyte subpopulations, delayed cutaneous hypersensitivity responses and mixed lymphocyte reactions in post‐menopausal women. Maturitas 1992; 14: 201–210
  • Savvas M., Studd J. W. W., Fogelman I., Dooley M., Montgomery J., Murby B. Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in the post menopausal woman. British Medical Journal 1988; 297: 331–333
  • Studd J., Garnett T. J. Hormone implants and tachyphylaxis (correspondence). British Journal of Obstetrics and Gynaecology 1991; 98: 502–503
  • Thorn M. H., Collins W. P., Studd J. W. W. Hormone profiles in postmenopausal women after therapy with subcutaneous implants. British Journal of Obstetrics and Gynaecology 1981; 88: 426–433

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.